Literature DB >> 26036358

Expression of oncogenic BRAFV600E in melanocytes induces Schwannian differentiation in vivo.

Chi Luo1,2, Jodie R Pietruska2,3, Jinghao Sheng2,4, Roderick T Bronson5, Miaofen G Hu2, Rutao Cui6, Philip W Hinds1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26036358      PMCID： PMC4539285          DOI： 10.1111/pcmr.12384

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  11 in total

1.  Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.

Authors:  Diane L Sherman; Michiel Krols; Lai-Man N Wu; Matthew Grove; Klaus-Armin Nave; Yann-Gaël Gangloff; Peter J Brophy
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

2.  Clonally cultured differentiated pigment cells can dedifferentiate and generate multipotent progenitors with self-renewing potential.

Authors:  Carla Real; Corinne Glavieux-Pardanaud; Nicole M Le Douarin; Elisabeth Dupin
Journal:  Dev Biol       Date:  2006-09-26       Impact factor: 3.582

3.  Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.

Authors:  Victoria Marsh Durban; Marian M Deuker; Marcus W Bosenberg; Wayne Phillips; Martin McMahon
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 4.  No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.

Authors:  Maria Romina Girotti; Grazia Saturno; Paul Lorigan; Richard Marais
Journal:  Mol Oncol       Date:  2014-08-15       Impact factor: 6.603

5.  mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.

Authors:  William Damsky; Goran Micevic; Katrina Meeth; Viswanathan Muthusamy; David P Curley; Manjula Santhanakrishnan; Ildiko Erdelyi; James T Platt; Laura Huang; Nicholas Theodosakis; M Raza Zaidi; Scott Tighe; Michael A Davies; David Dankort; Martin McMahon; Glenn Merlino; Nabeel Bardeesy; Marcus Bosenberg
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

6.  Expression of Schwann cell characteristics in pigmented nevus. Immunohistochemical study using monoclonal antibody to Schwann cell associated antigen.

Authors:  M Aso; K Hashimoto; H Eto; T Fukaya; M Ishihara; S Shimao; Y Shimizu
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

7.  Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression.

Authors:  J A Reed; B Finnerty; A P Albino
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin.

Authors:  Igor Adameyko; Francois Lallemend; Jorge B Aquino; Jorge A Pereira; Piotr Topilko; Thomas Müller; Nicolas Fritz; Anna Beljajeva; Makoto Mochii; Isabel Liste; Dmitry Usoskin; Ueli Suter; Carmen Birchmeier; Patrik Ernfors
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

9.  Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.

Authors:  V K Goel; N Ibrahim; G Jiang; M Singhal; S Fee; T Flotte; S Westmoreland; F S Haluska; P W Hinds; F G Haluska
Journal:  Oncogene       Date:  2009-04-27       Impact factor: 9.867

10.  Oncogenic Braf induces melanocyte senescence and melanoma in mice.

Authors:  Nathalie Dhomen; Jorge S Reis-Filho; Silvy da Rocha Dias; Robert Hayward; Kay Savage; Veronique Delmas; Lionel Larue; Catrin Pritchard; Richard Marais
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743
View more
  7 in total

1.  H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP.

Authors:  Chi Luo; Eduardo Balsa; Elizabeth A Perry; Jiaxin Liang; Clint D Tavares; Francisca Vazquez; Hans R Widlund; Pere Puigserver
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

2.  ERRα Maintains Mitochondrial Oxidative Metabolism and Constitutes an Actionable Target in PGC1α-Elevated Melanomas.

Authors:  Chi Luo; Eduardo Balsa; Ajith Thomas; Maximilian Hatting; Mark Jedrychowski; Steven P Gygi; Hans R Widlund; Pere Puigserver
Journal:  Mol Cancer Res       Date:  2017-06-08       Impact factor: 5.852

3.  Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth.

Authors:  Galina V Shurin; Oleg Kruglov; Fei Ding; Yan Lin; Xingxing Hao; Anton A Keskinov; Zhaoyang You; Anna E Lokshin; William A LaFramboise; Louis D Falo; Michael R Shurin; Yuri L Bunimovich
Journal:  Cancer Res       Date:  2019-03-26       Impact factor: 12.701

4.  Classification and Grading of Melanocytic Lesions in a Mouse Model of NRAS-driven Melanomagenesis.

Authors:  Charles-Antoine Assenmacher; Sara F Santagostino; Mark A Oyama; Jean-Christophe Marine; Elise Bonvin; Enrico Radaelli
Journal:  J Histochem Cytochem       Date:  2020-12-07       Impact factor: 2.479

5.  Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome.

Authors:  Lu Zhou; Jiaqi Wang; Tailing Wang
Journal:  BMC Med Genet       Date:  2018-07-20       Impact factor: 2.103

6.  Amphiregulin Regulates Melanocytic Senescence.

Authors:  Michaela Pommer; Silke Kuphal; Anja K Bosserhoff
Journal:  Cells       Date:  2021-02-05       Impact factor: 6.600

7.  HCV poly U/UC sequence-induced inflammation leads to metabolic disorders in vulvar lichen sclerosis.

Authors:  Qing Cong; Xiao Guo; Shengwei Zhang; Jinhui Wang; Yi Zhu; Lili Wang; Guangxing Lu; Yufeng Zhang; Wei Fu; Liying Zhou; Shuaikang Wang; Cenxi Liu; Jia Song; Chaoyong Yang; Chi Luo; Ting Ni; Long Sui; He Huang; Jin Li
Journal:  Life Sci Alliance       Date:  2021-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.